Semigran Marc - 20 Dec 2021 Form 4 Insider Report for Renovacor, Inc. (RCOR)

Role: Chief Medical Officer
Signature: By: /s/ Joseph Carroll, as attorney- in-fact
Issuer symbol: RCOR
Transactions as of: 20 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 22 Dec 2021, 15:30:30 UTC
Previous filing: 08 Sep 2021
Next filing: 26 Jan 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCOR	Stock Option	Award	$0	+89K		$0.00	89K	20 Dec 2021	Common Stock	89K	$10.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 2, 2021, the Reporting Person was granted a stock option that will vest and become exercisable in full on December 2, 2021, subject to the achievement of certain performance based milestones set forth in the Employment Agreement by and between the Issuer and the Reporting Person, dated May 5, 2021 (with the achievement of such performance based milestones subject to the approval of the Compensation Committee of the Board of Directors of the Issuer), and the continuous service of the Reporting Person on such vesting date. On December 20, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria was met, resulting in the vesting of the option as to 88,991 shares as of such vesting date.

Content

On September 2, 2021, the Reporting Person was granted a stock option that will vest and become exercisable in full on December 2, 2021, subject to the achievement of certain performance based milestones set forth in the Employment Agreement by and between the Issuer and the Reporting Person, dated May 5, 2021 (with the achievement of such performance based milestones subject to the approval of the Compensation Committee of the Board of Directors of the Issuer), and the continuous service of the Reporting Person on such vesting date. On December 20, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria was met, resulting in the vesting of the option as to 88,991 shares as of such vesting date.